Black silicon prevents eye implant from gumming up

April 14, 2017 by Robert Perkins, California Institute of Technology
Artist's depiction of an ocular implant. Credit: Lee, Jeong Oen, Vinayak Narasimhan, Juan Du, David W. Sretavan, and Hyuck Choo: "Black-Silicon as a Biocompatible Anti-Reflection Coating for Medical Implants: First Demonstrated Use in In vivo Optical Intraocular Pressure Sensing.” Advanced Healthcare Materials. 2017. Volume 6. Cover. Credit: Wiley-VCH Verlag GmbH & Co. KGaA

A team of researchers led by Caltech's Hyuck Choo has developed an eye implant for glaucoma patients that could one day lead to more timely and effective treatment.

If you have ever been to an ophthalmologist, you have probably had your checked: with your chin resting on a support to keep your head still, the doctor applies pressure to your eye either via a puff of warm air or by gently pressing a probe against the eye's . By measuring the amount that surface deforms as a result of a known amount of pressure, the ophthalmologist can calculate a rough estimate of the intraocular pressure.

While effective enough for routine eye exams, the technique is not sufficient for patients suffering from glaucoma. Glaucoma affects more than 2 million people in the United States, and is the second leading cause of blindness after cataracts. It is actually a family of eye diseases that are characterized by an increase in the pressure of the fluid inside the eye. That pressure damages the optic nerve at the back of the eye.

Glaucoma patients can experience episodes of elevated eye pressure that occur relatively suddenly, over the course of a few hours. To prevent permanent damage, it is crucial to swiftly apply medication to reduce that pressure. As such, glaucoma patients would benefit from easier and more accurate readings, says Choo, assistant professor of electrical engineering in the Division of Engineering and Applied Science and a Heritage Medical Research Institute Investigator.

"For glaucoma patients, it's important to be able to take regular and exact measurements of eye pressure. It would be good if that didn't require constantly visiting a doctor's office," he says.

Choo leads a team in the Andrew and Peggy Cherng Department of Medical Engineering at Caltech that has developed a novel eye designed to measure intraocular pressure. While he is still fine-tuning his design, he estimates that it could be ready for FDA review within a few years.

Eye implants to measure pressure already exist, but those devices are several millimeters in diameter—bulky for an object that has to be inserted into the eye—because they require battery-powered electronics as well as antennae to transmit the data they collect.

By contrast, Choo has developed a passive system that eschews electronics and so needs no batteries and has no antennae. At just 600–800 micrometers in diameter, the sensor is the width of a few strands of hair. It consists of a flat cylinder, just 600 micrometers in overall height, with a reflective surface on the back and a deformable membrane at the front. The tiny gadget is designed to be implanted just below the surface of the eye, where it can detect pressure changes in eye fluid.

To gauge the pressure inside the eye, a handheld device, designed by the team, is used to shine a light onto the implant. Changing eye deforms the implant's membrane, altering the distance between the membrane and the reflective surface; this, in turn, alters the wavelength of the light that is reflected off that surface. Measuring the wavelength of the reflected light, then, gives a direct measure of .

"A doctor implants the sensor in the eye, and then you can scan it any time you like with a device that's as simple to use as a supermarket checkout stand's barcode scanner," says Vinayak Narasimhan, graduate student in .

A smaller device could be inserted with a smaller incision that would allow patients to recover more quickly. Further, because they lack electronics, Choo's implants have a potentially limitless lifetime.

One obstacle that all bioimplants face, however, is fouling by the body's own defense mechanisms. To a white blood cell, a vision-saving is no different than a vision-destroying microbe. Both will be treated as a foreign invader, and attacked. This immune system assault can lead to the accretion of cellular material around the implants, reducing their effectiveness.

One potential solution, as Choo and his team reported in a recent paper in the journal Advanced Healthcare Materials, involves using an exterior ring made of silicon that is "rough" at the nanoscale, so that it scatters light rather than reflecting it. That light-scattering rough surface—which gives the ring a black appearance—also discourages cells from latching onto the device, preventing it from getting gummed up by biomaterial after implantation. Furthermore, the fact that black silicon does not reflect light well makes it easier for the handheld sensor to get a reading from the inside the device.

Next, the team plans to explore other materials that could further improve the device's functionality.

Explore further: New device could save glaucoma patients' eyesight

More information: Jeong Oen Lee et al. Biocompatible Multifunctional Black-Silicon for Implantable Intraocular Sensor, Advanced Healthcare Materials (2017). DOI: 10.1002/adhm.201601356

Related Stories

ECP, second drainage device effective in refractory glaucoma

September 1, 2016

(HealthDay)—For patients with refractory glaucoma with failed initial tube shunt, both endoscopic cyclophotocoagulation (ECP) and implantation of a second glaucoma drainage device (GDD-2) are effective as second surgeries, ...

Researchers develop artificial lens based glaucoma sensor

August 25, 2014

(Medical Xpress)—A team of researchers working at Stanford University has developed a glaucoma sensor that fits onto an artificial lens. The sensor works in conjunction with a smartphone peripheral and app, and allows the ...

Eye implant could lead to better glaucoma treatment

August 26, 2014

For the 2.2 million Americans battling glaucoma, the main course of action for staving off blindness involves weekly visits to eye specialists, who monitor—and control—increasing pressure within the eye.

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.